Similar Posts
Small Pharma Clinical Trials to Study DMT for Treatment-Resistant Depression
Small Pharma is going into clinical trials to look at DMT for depression relief. The UK company says it believes benefits will be immediate.
Peter Thiel-Backed Atai Life Sciences Announces IPO With $2 Billion Valuation
Atai Life Sciences is the latest psychedelic company to announce plans to IPO. The Peter Thiel-backed biotech startup is valued at more than $2 billion.
Uncovering the Mysteries of LSD: New Study Examines How it Alters Brain Connections
A new study published in the Journal of Psychopharmacology investigating LSD’s effects on the brain reveals interesting findings.
How a Psychedelic Experience Led to the Formation of the Extinction Rebellion
A psychedelic experience helped create the environmental activist organization known as Extinction Rebellion.
Psychedelic Business Spotlight – May 6
This week in psychedelic business news: Wesana Health pivots strategy; Compass Pathways makes progress on anorexia; Completion launches psychedelic VR NFTs.
Psychedelic Business News Spotlight: April 9, 2021
This week in psychedelic business news: a psilocybin delivery system for brain inflammation, a genetic test to predict your psychedelic-assisted therapy experience, and a potential first treatment for a debilitating form of schizophrenia.